Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma

OncoImmunology

Volumn 4, Issue 1, 2015, Pages 965570-

  Partlová, Simona ^a,b   Bouček, Jan ^b,c   Kloudová, Kamila ^a,b   Lukešová, Eva ^d,e   Zábrodský, Michal ^b   Grega, Marek ^b   Fučíková, Jitka ^a,b   Truxová, Iva ^a   Tachezy, Ruth ^d,e   Špíšek, Radek ^a,b   Fialová, Anna ^a,b  

^a Sotio   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^c INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^d INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^e CHARLES UNIVERSITY   (Czech Republic)

Author keywords

CD8+ T lymphocytes; HNSCC; HPV; PD 1; Tim 3

Indexed keywords

CD123 ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD45 ANTIGEN; CXCL9 CHEMOKINE; CYCLOOXYGENASE 2; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 4; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MESSENGER RNA; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1; T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN 3; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOCYTE; MYELOID DENDRITIC CELL; OUTCOME ASSESSMENT; PAPILLOMAVIRUS INFECTION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; RNA EXTRACTION; TH1 CELL; TH17 CELL; TREATMENT RESPONSE; TUMOR ASSOCIATED LEUKOCYTE;

EID: 84938717670     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/21624011.2014.965570     Document Type: Article

References (55)

1. A.Nasman, P.Attner, L.Hammarstedt, J.Du, M.Eriksson, G.Giraud, S.Ahrlund-Richter, L.Marklund, M.Romanitan, D.Lindquist Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009; 125:362-6; PMID:19330833; dx.doi.org/10.1002/ijc.24339
2. C.B.Lajer, C.von Buchwald. The role of human papillomavirus in head and neck cancer. APMIS 2010; 118:510-9; PMID:20553531; dx.doi.org/10.1111/j.1600-0463.2010.02624.x
3. L.Licitra, F.Perrone, P.Bossi, S.Suardi, L.Mariani, R.Artusi, M.Oggionni, C.Rossini, G.Cantu, M.Squadrelli High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 2006; 24:5630-6; PMID:17179101; dx.doi.org/10.1200/JCO.2005.04.6136
4. P.Lassen, J.G.Eriksen, S.Hamilton-Dutoit, T.Tramm, J.Alsner, J.Overgaard. Effect of HPV-associated p16INK4 A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol 2009; 27:1992-8; PMID:19289615; dx.doi.org/10.1200/JCO.2008.20.2853
5. W.C.Spanos, P.Nowicki, D.W.Lee, A.Hoover, B.Hostager, A.Gupta, M.E.Anderson, J.H.Lee. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer. Arch Otolaryngol Head Neck Surg 2009; 135:1137-46; PMID:19917928; dx.doi.org/10.1001/archoto.2009.159
6. R.J.Kimple, P.M.Harari, A.D.Torres, R.Z.Yang, B.J.Soriano, M.Yu, E.A.Armstrong, G.C.Blitzer, M.A.Smith, L.D.Lorenz Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgrafts. Clin Cancer Res 2013; 19:855-64; PMID:23251001; dx.doi.org/10.1158/1078-0432.CCR-12-2746
7. J.Galon, A.Costes, F.Sanchez-Cabo, A.Kirilovsky, B.Mlecnik, C.Lagorce-Pages, M.Tosolini, M.Camus, A.Berger, P.Wind Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960-4; PMID:17008531; dx.doi.org/10.1126/science.1129139
8. C.G.Clemente, M.C.MihmJr, R.Bufalino, S.Zurrida, P.Collini, N.Cascinelli. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996; 77:1303-10; PMID:8608507; dx.doi.org/10.1002/(SICI)1097-0142(19960401)77:7%3c1303::AID-CNCR12%3e3.0.CO;2-5
9. +regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 2005; 102:18538-43; PMID:16344461; dx.doi.org/10.1073/pnas.0509182102
10. P.Kocian, M.Sedivcova, J.Drgac, K.Cerna, J.Hoch, R.Kodet, J.Bartunkova, R.Spisek, A.Fialova. Tumor-infiltrating lymphocytes and dendritic cells in human colorectal cancer: their relationship to KRAS mutational status and disease recurrence. Hum Immunol 2011; 72:1022-8; PMID:21884745; dx.doi.org/10.1016/j.humimm.2011.07.312
11. O.Kawai, G.Ishii, K.Kubota, Y.Murata, Y.Naito, T.Mizuno, K.Aokage, N.Saijo, Y.Nishiwaki, A.Gemma Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Cancer 2008; 113:1387-95; PMID:18671239; dx.doi.org/10.1002/cncr.23712
12. D.Wansom, E.Light, F.Worden, M.Prince, S.Urba, D.B.Chepeha, K.Cordell, A.Eisbruch, J.Taylor, N.D’Silva Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal cancer. Arch Otolaryngol Head Neck Surg 2010; 136:1267-73; PMID:21173378; dx.doi.org/10.1001/archoto.2010.211
13. + and Foxp3 +lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer. PLoS One 2012; 7:e38711; PMID:22701698; dx.doi.org/10.1371/journal.pone.0038711
14. C.Nordfors, N.Grun, N.Tertipis, A.Ahrlund-Richter, L.Haeggblom, L.Sivars, J.Du, T.Nyberg, L.Marklund, E.Munck-Wikland CD8(+) and CD4(+) tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma. Eur J Cancer 2013; 49:2522-30; PMID:23571147; dx.doi.org/10.1016/j.ejca.2013.03.019
15. A.Fialova, S.Partlova, L.Sojka, H.Hromadkova, T.Brtnicky, J.Fucikova, P.Kocian, L.Rob, J.Bartunkova, R.Spisek. Dynamics of T-cell infiltration during the course of ovarian cancer: the gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells. Int J Cancer 2013; 132:1070-9; PMID:22865582; dx.doi.org/10.1002/ijc.27759
16. + T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 1998; 58:3491-4; PMID:9721846
17. + T cells. BMC Cancer 2013; 13:592; PMID:24330498; dx.doi.org/10.1186/1471-2407-13-592
18. C.Badoual, S.Hans, N.Merillon, C.Van Ryswick, P.Ravel, N.Benhamouda, E.Levionnois, M.Nizard, A.Si-Mohamed, N.Besnier PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. Cancer Res 2013; 73:128-38; PMID:23135914; dx.doi.org/10.1158/0008-5472.CAN-12-2606
19. T.J.Curiel, G.Coukos, L.Zou, X.Alvarez, P.Cheng, P.Mottram, M.Evdemon-Hogan, J.R.Conejo-Garcia, L.Zhang, M.Burow Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10:942-9; PMID:15322536; dx.doi.org/10.1038/nm1093
20. C.Miracco, V.Mourmouras, M.Biagioli, P.Rubegni, S.Mannucci, I.Monciatti, E.Cosci, P.Tosi, P.Luzi. Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma. Oncol Rep 2007; 18:1115-22; PMID:17914561; dx.doi.org/10.3892/or.18.5.1115
21. S.D.Bohling, K.H.Allison. Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target. Mod Pathol 2008; 21:1527-32; PMID:18820666; dx.doi.org/10.1038/modpathol.2008.160
22. N.Hiraoka, K.Onozato, T.Kosuge, S.Hirohashi. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 2006; 12:5423-34; PMID:17000676; dx.doi.org/10.1158/1078-0432.CCR-06-0369
23. P.Salama, M.Phillips, F.Grieu, M.Morris, N.Zeps, D.Joseph, C.Platell, B.Iacopetta. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 2009; 27:186-92; PMID:19064967; dx.doi.org/10.1200/JCO.2008.18.7229
24. T.Alvaro, M.Lejeune, M.T.Salvado, R.Bosch, J.F.Garcia, J.Jaen, A.H.Banham, G.Roncador, C.Montalban, M.A.Piris. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 2005; 11:1467-73; PMID:15746048; dx.doi.org/10.1158/1078-0432.CCR-04-1869
25. + T-cell subpopulations in head and neck cancers. Clin Cancer Res 2006; 12:465-72; PMID:16428488; dx.doi.org/10.1158/1078-0432.CCR-05-1886
26. L.Bron, C.Jandus, S.Andrejevic-Blant, D.E.Speiser, P.Monnier, P.Romero, J.P.Rivals. Prognostic value of arginase-II expression and regulatory T-cell infiltration in head and neck squamous cell carcinoma. Int J Cancer 2013; 132:E85-93; PMID:22815199; dx.doi.org/10.1002/ijc.27728
27. D.Loose, A.Signore, E.Bonanno, H.Vermeersch, R.Dierckx, P.Deron,C. Van de Wiele. Prognostic value of CD25 expression on lymphocytes and tumor cells in squamous-cell carcinoma of the head and neck. Cancer Biother Radiopharm 2008; 23:25-33; PMID:18298326; dx.doi.org/10.1089/cbr.2007.0373
28. J.Boucek, T.Mrkvan, M.Chovanec, M.Kuchar, J.Betka, V.Boucek, M.Hladikova, J.Betka, T.Eckschlager, B.Rihova. Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck. J Cell Mol Med 2010; 14:426-33; PMID:19183242; dx.doi.org/10.1111/j.1582-4934.2008.00650.x
29. M.Heusinkveld, R.Goedemans, R.J.Briet, H.Gelderblom, J.W.Nortier, A.Gorter, V.T.Smit, A.P.Langeveld, J.C.Jansen, S.H.van der Burg. Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer. Int J Cancer 2012; 131:E74-85; PMID:22020783; dx.doi.org/10.1002/ijc.26497
30. S.J.Piersma, M.J.Welters, J.M.van der Hulst, J.N.Kloth, K.M.Kwappenberg, B.J.Trimbos, C.J.Melief, B.W.Hellebrekers, G.J.Fleuren, G.G.Kenter Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction element. Int J Cancer 2008; 122:486-94; PMID:17955486; dx.doi.org/10.1002/ijc.23162
31. + T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine. Clin Cancer Res 2008; 14:178-87; PMID:18172269; dx.doi.org/10.1158/1078-0432.CCR-07-1880
32. B.Marcus, D.Arenberg, J.Lee, C.Kleer, D.B.Chepeha, C.E.Schmalbach, M.Islam, S.Paul, Q.Pan, S.Hanash Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma. Cancer 2004; 101:2779-87; PMID:15546137; dx.doi.org/10.1002/cncr.20701
33. A.Lam-ubol, D.Hopkin, E.M.Letuchy, Z.B.Kurago. Squamous carcinoma cells influence monocyte phenotype and suppress lipopolysaccharide-induced TNF-alpha in monocytes. Inflammation 2010; 33:207-23; PMID:20084448; dx.doi.org/10.1007/s10753-009-9175-6
34. T.T.Tan, L.M.Coussens. Humoral immunity, inflammation and cancer. Curr Opin Immunol 2007; 19:209-16; PMID:17276050; dx.doi.org/10.1016/j.coi.2007.01.001
35. + CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007; 81:584-92; PMID:17135573; dx.doi.org/10.1189/jlb.0806510
36. L.V.Ramanathapuram, D.Hopkin, Z.B.Kurago. Dendritic Cells (DC) facilitate detachment of squamous carcinoma cells (SCC), while SCC promote an immature CD16(+) DC phenotype and control DC migration. Cancer Microenviron 2013; 6:41-55; PMID:21809059; dx.doi.org/10.1007/s12307-011-0077-4
37. A.Muller, B.Homey, H.Soto, N.Ge, D.Catron, M.E.Buchanan, T.McClanahan, E.Murphy, W.Yuan, S.N.Wagner Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410:50-6; PMID:11242036; dx.doi.org/10.1038/35065016
38. M.Cojoc, C.Peitzsch, F.Trautmann, L.Polishchuk, G.D.Telegeev, A.Dubrovska. Emerging targets in cancer management: role of the CXCL12CXCR4 axis. Onco Targets Ther 2013; 6:1347-61; PMID:24124379; dx.doi.org/10.2147/OTT.S36109
39. J.Alferink, I.Lieberam, W.Reindl, A.Behrens, S.Weiss, N.Huser, K.Gerauer, R.Ross, A.B.Reske-Kunz, P.Ahmad-Nejad Compartmentalized production of CCL17 in vivo: strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen. J Exp Med 2003; 197:585-99; PMID:12615900; dx.doi.org/10.1084/jem.20021859
40. R.A.Gupta, R.N.Dubois. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 2001; 1:11-21; PMID:11900248; dx.doi.org/10.1038/35094017
41. L.R.Howe, K.Subbaramaiah, A.M.Brown, A.J.Dannenberg. Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. Endocr Relat Cancer 2001; 8:97-114; PMID:11397667; dx.doi.org/10.1677/erc.0.0080097
42. A.Ristimaki, A.Sivula, J.Lundin, M.Lundin, T.Salminen, C.Haglund, H.Joensuu, J.Isola. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 2002; 62:632-5; PMID:11830510
43. I.Melero, S.Hervas-Stubbs, M.Glennie, D.M.Pardoll, L.Chen. Immunostimulatory monoclonal antibodies for cancer therapy. Nat Rev Cancer 2007; 7:95-106; PMID:17251916; dx.doi.org/10.1038/nrc2051
44. S.N.Mueller, R.Ahmed. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc Natl Acad Sci USA 2009; 106:8623-8; PMID:19433785; dx.doi.org/10.1073/pnas.0809818106
45. J.S.Yi, M.A.Cox, A.J.Zajac. T-cell exhaustion: characteristics, causes and conversion. Immunology 2010; 129:474-81; PMID:20201977; dx.doi.org/10.1111/j.1365-2567.2010.03255.x
46. E.J.Wherry. T cell exhaustion. Nat Immunol 2011; 12:492-9; PMID:21739672; dx.doi.org/10.1038/ni.2035
47. X.Gao, Y.Zhu, G.Li, H.Huang, G.Zhang, F.Wang, J.Sun, Q.Yang, X.Zhang, B.Lu. TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression. PLoS One 2012; 7:e30676; PMID:22363469; dx.doi.org/10.1371/journal.pone.0030676
48. Z.Z.Yang, D.M.Grote, S.C.Ziesmer, T.Niki, M.Hirashima, A.J.Novak, T.E.Witzig, S.M.Ansell. IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma. J Clin Invest 2012; 122:1271-82; PMID:22426209; dx.doi.org/10.1172/JCI59806
49. E.Koslabova, E.Hamsikova, M.Salakova, J.Klozar, E.Foltynova, E.Salkova, E.Rotnaglova, V.Ludvikova, R.Tachezy. Markers of HPV infection and survival in patients with head and neck tumors. Int J Cancer 2013; 133:1832-9; PMID:23564321; dx.doi.org/10.1002/ijc.28194
50. E.Rotnaglova, R.Tachezy, M.Salakova, B.Prochazka, E.Kosl’abova, E.Vesela, V.Ludvikova, E.Hamsikova, J.Klozar. HPV involvement in tonsillar cancer: prognostic significance and clinically relevant markers. Int J Cancer 2011; 129:101-10; PMID:21190188; dx.doi.org/10.1002/ijc.25889
51. J.Klozar, V.Kratochvil, M.Salakova, J.Smahelova, E.Vesela, E.Hamsikova, J.Betka, R.Tachezy. HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol 2008; 265 Suppl 1:S75-82; PMID:18094985; dx.doi.org/10.1007/s00405-007-0557-9
52. R.Tachezy, J.Klozar, M.Salakova, E.Smith, L.Turek, J.Betka, R.Kodet, E.Hamsikova. HPV and other risk factors of oral cavityoropharyngeal cancer in the Czech Republic. Oral Dis 2005; 11:181-5; PMID:15888110; dx.doi.org/10.1111/j.1601-0825.2005.01112.x
53. A.J.van den Brule, R.Pol, N.Fransen-Daalmeijer, L.M.Schouls, C.J.Meijer, P.J.Snijders. GP5+6 +PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002; 40:779-87; PMID:11880393; dx.doi.org/10.1128/JCM.40.3.779-787.2002
54. P.E.Gravitt, C.Peyton, C.Wheeler, R.Apple, R.Higuchi, K.V.Shah. Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays. J Virol Methods 2003; 112:23-33; PMID:12951209; dx.doi.org/10.1016/S0166-0934(03)00186-1
55. S.J.Smeets, A.T.Hesselink, E.J.Speel, A.Haesevoets, P.J.Snijders, M.Pawlita, C.J.Meijer, B.J.Braakhuis, C.R.Leemans, R.H.Brakenhoff. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007; 121:2465-72; PMID:17680565; dx.doi.org/10.1002/ijc.22980